Haemonetics Corp

• A Board Member Bet $1.1 Million on This Stock

  By Meena Krishnamsetty - March 18, 2013 | Tickers: DXCM, HAE, HRC, MDT

  According to a Form 4 filed with the SEC, Jay Skyler of DexCom (NASDAQ: DXCM) directly purchased 70,000 shares of stock on March 11 at an average price of $15.50 per share. Between his direct holdings and his trust, he now owns over 250,000 shares of the stock (his family owns another 20,000 shares), so this was a significant percentage increase in his holdings. Studies show more »

• Does This Stock's Growth Prospects Justify its Valuation?

  By Lee Samaha - September 16, 2012 | Tickers: MMM, HAE, INTC, PLL, BA

  Filtration company Pall Corp (NYSE: PLL) gave full year results recently and confirmed why it appears to be the kind of stock that long term investors should favor. Its long term revenue drivers are guided by regulatory and environmental quality concerns and it combines a cyclical division (industrial) with a more defensive division (life sciences). This gives it the opportunity to grow across the economic cycle.

  Pall operates the kind more »